[HTML][HTML] Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?
JGF Cleland - Thrombosis and Haemostasis, 2022 - thieme-connect.com
Recent trials suggest that aspirin does not reduce cardiovascular events or increase
longevity in people who are not known to have cardiovascular disease, 1 leading to draft …
longevity in people who are not known to have cardiovascular disease, 1 leading to draft …
[引用][C] Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
JGF Cleland - Thrombosis and Haemostasis, 2022 - europepmc.org
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
[PDF][PDF] Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?
JGF Cleland - Thrombosis and Haemostasis, 2022 - eprints.gla.ac.uk
Recent trials suggest that aspirin does not reduce cardiovascular events or increase
longevity in people who are not known to have cardiovascular disease, 1 leading to draft …
longevity in people who are not known to have cardiovascular disease, 1 leading to draft …
[引用][C] Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
JGF Cleland - Thrombosis and haemostasis, 2022 - pubmed.ncbi.nlm.nih.gov